Cause of death in Chinese Takayasu arteritis patients

Jing Li1, Mengzhu Zhu, Mengtao Li

  • 1Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Key Laboratory of Rheumatology and Clinical Immunology, Beijing Department of Rheumatology, Chinese Medicine Hospital in Linyi City, Linyi, Shandong, China.

Medicine
|July 12, 2016
PubMed

Insights

Heart failure is the leading cause of death in Takayasu arteritis (TAK) patients, with secondary hypertension and longer disease duration also increasing mortality risk. Active disease, however, is associated with lower mortality.

Area of Science:

  • Rheumatology
  • Cardiology
  • Internal Medicine

Background:

  • Takayasu arteritis (TAK) is a rare, chronic inflammatory disease affecting large arteries, primarily the aorta and its branches.
  • Understanding mortality causes and risk factors in TAK is crucial for improving patient outcomes.
  • Previous studies have focused on disease prevalence and management, with limited data on specific mortality predictors in Chinese populations.

Purpose of the Study:

  • To investigate the causes of death and identify risk factors associated with mortality in hospitalized Takayasu arteritis patients.
  • To analyze demographic, clinical, and angiographic data of deceased TAK patients compared to a matched control group.
  • To provide insights for better management strategies and long-term prognosis in TAK.

Main Methods:

  • Retrospective analysis of medical charts from 12 deceased TAK patients and 40 age- and sex-matched controls admitted between 1983 and 2014.
  • Review of demographic data, clinical manifestations, angiographic findings, and direct causes of death by senior rheumatologists.
  • Binary logistic regression analysis to identify risk factors for TAK mortality.

Main Results:

  • The leading causes of death were heart failure (41.7%), hemorrhage (16.7%), and pulmonary infection (16.7%).
  • Deceased patients exhibited longer disease duration, higher prevalence of active disease, secondary hypertension, and congestive heart failure compared to controls.
  • Secondary hypertension (OR=9.333), congestive heart failure (OR=5.667), and longer disease duration (OR=1.007) were significant risk factors for mortality, while active disease (OR=0.167) showed a protective association.

Conclusions:

  • Heart failure is the primary cause of mortality in TAK patients, followed by ischemia and pulmonary infections.
  • Effective management of hypertension and prevention of congestive heart failure are critical for improving long-term survival in TAK.
  • While early deaths can occur postoperatively, active disease appears to be associated with a reduced risk of mortality.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
522
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
484
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
763
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
707
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
480